Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation

Leukemia. 1997 Feb;11(2):299-300. doi: 10.1038/sj.leu.2400554.

Authors

J Boer¹, H Mahmoud, S Raimondi, G Grosveld, R Krance

Affiliation

¹ Department of Genetics, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

PMID: 9009096
DOI: 10.1038/sj.leu.2400554

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bone Marrow Transplantation*
Child, Preschool
Chromosomes, Human, Pair 6 / genetics*
Chromosomes, Human, Pair 6 / ultrastructure
Chromosomes, Human, Pair 9 / genetics*
Chromosomes, Human, Pair 9 / ultrastructure
Combined Modality Therapy
Humans
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / pathology
Leukemia, Myeloid, Acute / therapy
Male
Oncogene Proteins / genetics*
Oncogene Proteins, Fusion
RNA, Messenger / analysis*
RNA, Messenger / genetics
RNA, Neoplasm / analysis*
RNA, Neoplasm / genetics
Recombinant Fusion Proteins / genetics
Remission Induction
Translocation, Genetic / genetics*

Substances

DEK-CAN fusion protein, recombinant
Oncogene Proteins
Oncogene Proteins, Fusion
RNA, Messenger
RNA, Neoplasm
Recombinant Fusion Proteins